Investor Relations

Rigel's Mission

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

Rigel to Present at the Jefferies Virtual Healthcare Conference

View All

May 5, 2020 • 4:01 PM EDT

Rigel Reports First Quarter 2020 Financial Results and Provides Business Update

May 1, 2020 • 7:30 AM EDT

Rigel Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

Apr 27, 2020 • 7:30 AM EDT

Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update

May 2020

View Presentation

Jefferies 2020 Healthcare Conference

View Event Add to Calendar View All

Q1 2020

Quarter Ended Mar 31, 2020

Earnings Release

PDF HTML

Audio

Earnings Webcast

Earnings Presentation

PDF

10-Q

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Investor Contact Information

Company

Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd
South San Francisco, CA 94080